High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT05958537

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05958537
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05958537. Randomized; no masking; primary purpose treatment. Start 2023-11-01 (actual); primary completion 2024-07-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers
Acronym
HIGH-OXY-TAVR
Condition
Aortic Stenosis
Condition
Sedation Complication
Intervention (Device)
High flow nasal oxygen
Lead sponsor
Hospital Clinic of Barcelona (class: other)

Record details

Record id
cardio:ct-nct05958537
Content hash
4e48e1f2682729f4e85cb0f8b5434db1dad242955f92f98097a6423207006751